Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

Inclusion Criteria

• •Subjects meeting all of the following criteria were considered for enrollment into the study :
• •·Ambulatory, healthy postmenopausal women with :
• •Natural menopause and more than 5 years after their last menstrual period.
• •Or surgical menopause and more than 5 years after surgery (blood hormone tests required for subjects less than 65 years of age who had uterus removed without removal of ovaries at time of surgery).
• •Osteoporosis (lumbar spine T-score more than 2.5 SD below the mean value in normal young women or more than 2.0 SD below the mean value in normal young women and at least 1 fracture of a vertebra (thoracic-lumbar T4-L4)).